<SEC-DOCUMENT>0001015820-19-000021-index.html : 20190725
<SEC-HEADER>0001015820-19-000021.hdr.sgml : 20190725
<ACCEPTANCE-DATETIME>20190724190318
ACCESSION NUMBER:		0001015820-19-000021
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20190731
FILED AS OF DATE:		20190725
DATE AS OF CHANGE:		20190724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QIAGEN NV
		CENTRAL INDEX KEY:			0001015820
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38332
		FILM NUMBER:		19972058

	BUSINESS ADDRESS:	
		STREET 1:		HULSTERWEG 82
		CITY:			PL VENLO
		STATE:			P7
		ZIP:			5912
		BUSINESS PHONE:		31-77-35566-00

	MAIL ADDRESS:	
		STREET 1:		HULSTERWEG 82
		CITY:			PL VENLO
		STATE:			P7
		ZIP:			5912
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>pressrelease.htm
<DESCRIPTION>6-K
<TEXT>
Document 1 - file: pressrelease.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>qgennewheaderlogoa33.jpg
<TEXT>
Document 2 - file: qgennewheaderlogoa33.jpg

</DOCUMENT>
</SEC-DOCUMENT>